DiaMedica Therapeutics (DMAC) Insider Trading & Ownership → The #1 Crypto for AI (From Weiss Ratings) (Ad) Free DMAC Stock Alerts $3.25 -0.22 (-6.34%) (As of 05/9/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media DiaMedica Therapeutics (NASDAQ:DMAC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.20%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$5.49 MNumber OfInsiders Selling(Last 12 Months)0 Get DMAC Insider Trade Alerts Want to know when executives and insiders are buying or selling DiaMedica Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DMAC Insider Buying and Selling by Quarter Ad Weiss RatingsThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. DiaMedica Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/23/2023David J WambekeInsiderBuy38,364$3.91$150,003.24 6/23/2023Dietrich John PaulsCEOBuy12,787$3.91$49,997.17 6/23/2023Koch Thomas VonMajor ShareholderBuy1,470,588$3.40$4,999,999.20 6/23/2023Randall Michael GiuffreDirectorBuy65,000$3.91$254,150.00 6/23/2023Scott KellenCFOBuy10,000$3.91$39,100.00 (Data available from 1/1/2013 forward) DMAC Insider Trading Activity - Frequently Asked Questions Who is on DiaMedica Therapeutics's Insider Roster? The list of insiders at DiaMedica Therapeutics includes David J Wambeke, Dietrich John Pauls, Harry W Alcorn Jr, Koch Thomas Von, Randall Michael Giuffre, Richard D. Pilnik, and Scott Kellen. Learn more on insiders at DMAC. What percentage of DiaMedica Therapeutics stock is owned by insiders? 7.20% of DiaMedica Therapeutics stock is owned by insiders. Learn more on DMAC's insider holdings. Which DiaMedica Therapeutics insiders have been buying company stock? The following insiders have purchased DMAC shares in the last 24 months: David J Wambeke ($900,003.24), Dietrich John Pauls ($74,197.17), Koch Thomas Von ($5,276,604.62), Randall Michael Giuffre ($362,183.35), and Scott Kellen ($39,100.00). How much insider buying is happening at DiaMedica Therapeutics? Insiders have purchased a total of 2,380,021 DMAC shares in the last 24 months for a total of $6,652,088.38 bought. More Insider Trading Tools from MarketBeat Related Companies: Emergent BioSolutions Insider Trades IO Biotech Insider Trades Anixa Biosciences Insider Trades Clearside Biomedical Insider Trades Oramed Pharmaceuticals Insider Trades BioXcel Therapeutics Insider Trades Allakos Insider Trades PMV Pharmaceuticals Insider Trades OptiNose Insider Trades Cue Biopharma Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:DMAC) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
